ghk-cu human trials – True Lab Peptides ghk-cu injection clinical trial humans

The Ipamorelin versus CJC-1295 comparison helps determine which secretagogue fits your goals

2.0 mL gives ~2,500 mcg/mL for compact twice-daily doses

Published pharmacokinetic data for both peptides remain limited

Prepare injection site : Prep your chosen injection site (we usually recommend the stomach, thigh, or outer arm)

At baseline and at weeks 8 and 12, a clinician should assess fasting insulin and HOMA-IR (the homeostasis model assessment of insulin resistance, a calculated index derived from fasting glucose and insulin), HbA1c, high-sensitivity C-reactive protein as an inflammatory marker, and body composition by DEXA scan or bioelectrical impedance